Immune phenotype profiling based on anatomic origin of melanoma and impact on clinical outcomes of immune checkpoint inhibitor treatment. Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: ...
Comparison of classification systems in melanoma sentinel nodes: An analysis of 697 patients from a single center. Background: Use of immunohistochemistry (IHC) can increase the detection of ...
FRANKFURT, Germany--(BUSINESS WIRE)--NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstract describing ...
There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tissue tumor microenvironment. Conventional assays such as chromogenic immunohistochemistry ...
Immunohistochemistry (IHC) is a standard technique for scientists and pathologists to detect antigens. Examining one or two markers is a straightforward process but the level of complexity increases ...
Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...
INSM1 has been associated with regulation of the neuroendocrine differentiation pathway and increased expression in SCLC; however, its immunohistochemical expression and prognostic relevance are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback